Other grades of this product :
| LeterMovir Basic information |
| Product Name: | LeterMovir | | Synonyms: | AIC246;LeterMovir;(4S)-8-Fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetic acid;AIC246;AIC 246;AIC-246;CS-2799;4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-;Letermovir (AIC246);MK-8828 | | CAS: | 917389-32-3 | | MF: | C29H28F4N4O4 | | MW: | 572.55 | | EINECS: | | Product Categories: | API | | Mol File: | 917389-32-3.mol |
| LeterMovir Chemical Properties |
| Boiling point | 706.5±70.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | ≥57.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O | | form | solid | | pka | 4.00±0.10(Predicted) |
| LeterMovir Usage And Synthesis |
| Uses | Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems. |
| LeterMovir Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye